BIOMAT Database Logo BIOMAT Database Logo

Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients After Kidney Transplantation. 2018

Y Ayar, and A Ersoy, and G Ocakoglu, and E Gullulu, and H Kagızmanlı, and A Yıldız, and A Oruc, and M Yavuz, and M Gullulu, and K Dilek
Uludag University Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Bursa, Turkey. Electronic address: yavuzayar@hotmail.com.

OBJECTIVE Encapsulating peritoneal sclerosis (EPS) is a serious complication for patients with chronic kidney disease (CKD) who were treated with long-term peritoneal dialysis (PD). The risk of EPS was increased after kidney transplantation. In our study we evaluated risk factors for EPS patients after kidney transplantation who were treated before with PD. METHODS In our study, between January 2008 and August 2015, 47 PD patients (12 had EPS) who underwent kidney transplantation were analyzed. Age, gender, time of PD treatment, human leukocyte antigen (HLA) matching, cold ischemia time, kidney function (serum urea, creatinine, etc), comorbidities, immunosuppressive therapy, clinical features, and outcomes of PD patients were retrospectively evaluated in both groups. RESULTS Mean age was 42 (range, 25-60) years in EPS patients, versus 43 (range, 22-77) years without EPS (P = .798). Distribution of gender was similar in both groups (P = .154). The C-reactive protein levels (P < .001), number of patients with peritonitis (P = .001), length of time on PD (P < .001), and serum ferritin levels (P = .020) were higher in EPS patients. The immunosuppressive therapy was changed; tamoxifen and steroids were used after diagnosis in EPS patients. HLA matching was higher in the non-EPS group (P = .006). EPS was more often seen in patients who were treated with continuous ambulatory peritoneal dialysis (CAPD; 75%; P = .036). EPS was more often detected in cadaveric transplant recipients (83.3%; P = .024). High peritoneal transmittance rate was more identified in EPS (+) patients (P = .001). EPS was more often seen in patients who were treated with icodextrin-based regimens in PD before transplantation (91.7%; P = .037). The length of time on PD and high ferritin levels increased EPS 1.08 and 1.01, respectively (P = .036 and .049, respectively), in multivariate analysis. CONCLUSIONS The length of time on PD, type of PD, PD regimens with icodextrin, episodes of peritonitis, and peritoneal transmittance in patients with CKD affect the development of EPS after transplantation.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D010537 Peritoneum A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall. Parietal Peritoneum,Peritoneum, Parietal,Peritoneum, Visceral,Visceral Peritoneum,Parametrium,Parametriums
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D005936 Glucans Polysaccharides composed of repeating glucose units. They can consist of branched or unbranched chains in any linkages. Glucan,Polyglucose,Polyglucoses,Glucan (BO),Glucose Polymer,Polycose,Polymer, Glucose

Related Publications

Y Ayar, and A Ersoy, and G Ocakoglu, and E Gullulu, and H Kagızmanlı, and A Yıldız, and A Oruc, and M Yavuz, and M Gullulu, and K Dilek
Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients.
August 2005, Nephrology (Carlton, Vic.),
Y Ayar, and A Ersoy, and G Ocakoglu, and E Gullulu, and H Kagızmanlı, and A Yıldız, and A Oruc, and M Yavuz, and M Gullulu, and K Dilek
Encapsulating peritoneal sclerosis in patients on peritoneal dialysis.
January 2008, The Netherlands journal of medicine,
Y Ayar, and A Ersoy, and G Ocakoglu, and E Gullulu, and H Kagızmanlı, and A Yıldız, and A Oruc, and M Yavuz, and M Gullulu, and K Dilek
Encapsulating peritoneal sclerosis in patients on peritoneal dialysis.
October 2008, The Netherlands journal of medicine,
Y Ayar, and A Ersoy, and G Ocakoglu, and E Gullulu, and H Kagızmanlı, and A Yıldız, and A Oruc, and M Yavuz, and M Gullulu, and K Dilek
Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation.
August 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Y Ayar, and A Ersoy, and G Ocakoglu, and E Gullulu, and H Kagızmanlı, and A Yıldız, and A Oruc, and M Yavuz, and M Gullulu, and K Dilek
Encapsulating Peritoneal Sclerosis after kidney Transplantation: Success of Medical Treatment.
January 2021, Indian journal of nephrology,
Y Ayar, and A Ersoy, and G Ocakoglu, and E Gullulu, and H Kagızmanlı, and A Yıldız, and A Oruc, and M Yavuz, and M Gullulu, and K Dilek
CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosis.
December 2010, European journal of clinical investigation,
Y Ayar, and A Ersoy, and G Ocakoglu, and E Gullulu, and H Kagızmanlı, and A Yıldız, and A Oruc, and M Yavuz, and M Gullulu, and K Dilek
Encapsulating Peritoneal Sclerosis in Long-Termed Peritoneal Dialysis Patients.
January 2018, BioMed research international,
Y Ayar, and A Ersoy, and G Ocakoglu, and E Gullulu, and H Kagızmanlı, and A Yıldız, and A Oruc, and M Yavuz, and M Gullulu, and K Dilek
Encapsulating Peritoneal Sclerosis after Long-term Peritoneal Dialysis Treatment.
November 2020, Internal medicine (Tokyo, Japan),
Y Ayar, and A Ersoy, and G Ocakoglu, and E Gullulu, and H Kagızmanlı, and A Yıldız, and A Oruc, and M Yavuz, and M Gullulu, and K Dilek
Encapsulating peritoneal sclerosis in patients on peritoneal dialysis in Slovenia.
August 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
Y Ayar, and A Ersoy, and G Ocakoglu, and E Gullulu, and H Kagızmanlı, and A Yıldız, and A Oruc, and M Yavuz, and M Gullulu, and K Dilek
Posttransplantation encapsulating peritoneal sclerosis contributes significantly to mortality after kidney transplantation.
March 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Copied contents to your clipboard!